The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 16, 2019
Filed:
Jul. 16, 2018
Applicant:
Tian Xia, Chicago, IL (US);
Inventor:
Tian Xia, Chicago, IL (US);
Assignee:
Other;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/27 (2006.01); A61M 11/06 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61M 15/08 (2006.01); A61M 16/08 (2006.01); A61M 11/00 (2006.01); A61M 15/00 (2006.01); A61M 16/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/27 (2013.01); A61K 9/0043 (2013.01); A61K 45/06 (2013.01); A61M 11/007 (2014.02); A61M 11/06 (2013.01); A61M 15/08 (2013.01); A61M 16/0816 (2013.01); A61M 15/009 (2013.01); A61M 16/0461 (2013.01); A61M 2210/0618 (2013.01);
Abstract
Described herein is a method for treating a central nervous system disorder, said method comprising steps of first transnasally administering to or immediately adjacent the sphenopalatine ganglion a first pharmaceutical agent that effectively enhances permeability of the blood-brain barrier; and thereafter administering a second pharmaceutical agent with known efficacious value for action upon central nervous system tissue. The central nervous system disorder may be related directly to the brain or to other central nervous system tissues and cells.